Application and Utility of Liposomal Neuroprotective Agents and Biomimetic Nanoparticles for the Treatment of Ischemic Stroke
Ischemic stroke is still one of the leading causes of high mortality and severe disability worldwide. Therapeutic options for ischemic stroke and subsequent cerebral ischemia/reperfusion injury remain limited due to challenges associated with drug permeability through the blood-brain barrier (BBB)....
Saved in:
Main Authors: | Tatsuya Fukuta (Author), Naoto Oku (Author), Kentaro Kogure (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Engineered biomimetic drug-delivery systems for ischemic stroke therapy
by: Yue Yang, et al.
Published: (2022) -
Neuroprotective Effects of Stem Cells in Ischemic Stroke
by: Weilin Xu, et al.
Published: (2017) -
Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment
by: Farooqahmed S. Kittur, et al.
Published: (2023) -
Cannabinoids as Glial Cell Modulators in Ischemic Stroke: Implications for Neuroprotection
by: Andrés Vicente-Acosta, et al.
Published: (2022) -
Neuroprotective Effects of Quercetin on Ischemic Stroke: A Literature Review
by: Leilei Zhang, et al.
Published: (2022)